Epstein-Barr virus-positive nodal peripheral T cell lymphomas: Clinicopathologic and gene expression profiling study

Pathology Research and Practice

Volumn 209, Issue 7, 2013, Pages 448-454

  Ha, Sang Yun ^a   Sung, Jiyeon ^b   Ju, Hyunjung ^c   Karube, Kennosuke ^d   Kim, Soek Jin ^a   Kim, Won Seog ^a   Seto, Masao ^d   Ko, Young Hyeh ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Kyung Hee University Hospital   (South Korea)

^c Samsung Medical Center   (South Korea)

^d AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

EBV; Gene expression; Peripheral T cell lymphoma

Indexed keywords

CELL ANTIGEN; PROTEIN TIA 1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; B LYMPHOCYTE ACTIVATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIABETES MELLITUS; DOWN REGULATION; EPSTEIN BARR VIRUS INFECTION; EPSTEIN BARR VIRUS POSITIVE NODAL PERIPHERAL T CELL LYMPHOMA; FEMALE; GENE EXPRESSION PROFILING; GENE SEQUENCE; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNE DEFICIENCY; IMMUNE RESPONSE; LYMPHADENOPATHY; LYMPHOCYTIC INFILTRATION; MALE; MICROARRAY ANALYSIS; PERIPHERAL T CELL LYMPHOMA; PHENOTYPE; PROSTATE CANCER; RETROSPECTIVE STUDY; RNA ANALYSIS; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; UPREGULATION; VIRUS CARRIER;

EBV; GENE EXPRESSION; PERIPHERAL T CELL LYMPHOMA;

AGED; AGED, 80 AND OVER; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOMA, T-CELL, PERIPHERAL; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84880040198     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2013.04.013     Document Type: Article

References (38)

1. Asano N., Suzuki R., Kagami Y., Ishida F., Kitamura K., Fukutani H., Morishima Y., Takeuchi K., Nakamura S. Clinicopathologic and prognostic significance of cytotoxic molecule expression in nodal peripheral T-cell lymphoma, unspecified. Am. J. Surg. Pathol. 2005, 29:1284-1293.
2. Ballester B., Ramuz O., Gisselbrecht C., Doucet G., Loi L., Loriod B., Bertucci F., Bouabdallah R., Devilard E., Carbuccia N., Mozziconacci M.J., Birnbaum D., Brousset P., Berger F., Salles G., Briere J., Houlgatte R., Gaulard P., Xerri L. Gene expression profiling identifies molecular subgroups among nodal peripheral T-cell lymphomas. Oncogene 2006, 25:1560-1570.
3. Bensch K.W., Raida M., Magert H.J., Schulz-Knappe P., Forssmann W.G. hBD-1: a novel beta-defensin from human plasma. FEBS Lett. 1995, 368:331-335.
4. Chan J.K., Sin V.C., Wong K.F., Ng C.S., Tsang W.Y., Chan C.H., Cheung M.M., Lau W.H. Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. Blood 1997, 89:4501-4513.
5. Chen M.R. Epstein-Barr virus, the immune system, and associated diseases. Food Manage. 2011, 2:5.
6. Cuadros M., Dave S.S., Jaffe E.S., Honrado E., Milne R., Alves J., Rodriguez J., Zajac M., Benitez J., Staudt L.M., Martinez-Delgado B. Identification of a proliferation signature related to survival in nodal peripheral T-cell lymphomas. J. Clin. Oncol. 2007, 25:3321-3329.
7. Dahl C.A., Bach F.H., Chan W., Huebner K., Russo G., Croce C.M., Herfurth T., Cairns J.S. Isolation of a cDNA clone encoding a novel form of granzyme B from human NK cells and mapping to chromosome 14. Hum. Genet. 1990, 84:465-470.
8. Drebin J.A., Hartzell S.W., Griffin C., Campbell M.J., Niederhuber J.E. Molecular cloning and chromosomal localization of the human homologue of a B-lymphocyte specific protein tyrosine kinase (blk). Oncogene 1995, 10:477-486.
9. Dupuis J., Emile J.F., Mounier N., Gisselbrecht C., Martin-Garcia N., Petrella T., Bouabdallah R., Berger F., Delmer A., Coiffier B., Reyes F., Gaulard P. Prognostic significance of Epstein-Barr virus in nodal peripheral T-cell lymphoma, unspecified: a Groupe d'Etude des Lymphomes de l'Adulte (GELA) study. Blood 2006, 108:4163-4169.
10. Emelyanov A.V., Kovac C.R., Sepulveda M.A., Birshtein B.K. The interaction of Pax5 (BSAP) with Daxx can result in transcriptional activation in B cells. J. Biol. Chem. 2002, 277:11156-11164.
11. Fischer E., Delibrias C., Kazatchkine M.D. Expression of CR2 (the C3dg/EBV receptor, CD21) on normal human peripheral blood T lymphocytes. J. Immunol. 1991, 146:865-869.
12. Gupta-Rossi N., Storck S., Griebel P.J., Reynaud C.A., Weill J.C., Dahan A. Specific over-expression of deltex and a new Kelch-like protein in human germinal center B cells. Mol. Immunol. 2003, 39:791-799.
13. Haddad P., Jenne D., Tschopp J., Clement M.V., Mathieu-Mahul D., Sasportes M. Structure and evolutionary origin of the human granzyme H gene. Int. Immunol. 1991, 3:57-66.
14. Hatzivassiliou G., Miller I., Takizawa J., Palanisamy N., Rao P.H., Iida S., Tagawa S., Taniwaki M., Russo J., Neri A., Cattoretti G., Clynes R., Mendelsohn C., Chaganti R.S., Dalla-Favera R. IRTAI and IRTA2, novel immunoglobulin superfamily receptors expressed in B cells and involved in chromosome 1q21 abnormalities in B cell malignancy. Immunity 2001, 14:277-289.
15. Huang da W., Sherman B.T., Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 2009, 4:44-57.
16. Kanegane H., Miyawaki T., Yachie A., Oh-Ishi T., Bhatia K., Tosato G. Development of EBV-positive T-cell lymphoma following infection of peripheral blood T cells with EBV. Leuk. Lymphoma 1999, 34:603-607.
17. Kato S., Takahashi E., Asano N., Tanaka T., Megahed N., Kinoshita T., Nakamura S. Nodal cytotoxic molecule (CM)-positive Epstein-Barr virus (EBV)-associated peripheral T cell lymphoma (PTCL): a clinicopathological study of 26 cases. Histopathology 2012, 61:186-199.
18. Katz P., Whalen G., Kehrl J.H. Differential expression of a novel protein kinase in human B lymphocytes. Preferential localization in the germinal center. J. Biol. Chem. 1994, 269:16802-16809.
19. Kawasaki N., Rademacher C., Paulson J.C. CD22 regulates adaptive and innate immune responses of B cells. J. Innate Immun. 2011, 3:411-419.
20. Kitagawa Y., Liu C., Ding X. The influence of natural mineral water on aquaporin water permeability and human natural killer cell activity. Biochem. Biophys. Res. Commun. 2011, 409:40-45.
21. Laabi Y., Gras M.P., Brouet J.C., Berger R., Larsen C.J., Tsapis A. The BCMA gene, preferentially expressed during B lymphoid maturation, is bidirectionally transcribed. Nucleic Acids Res. 1994, 22:1147-1154.
22. Langer R., Geissinger E., Rudiger T., von Schilling C., Ott G., Mandl-Weber S., Quintanilla-Martinez L., Fend F. Peripheral T-cell lymphoma with progression to a clonally related, Epstein Barr virus+, cytotoxic aggressive T-cell lymphoma: evidence for secondary EBV infection of an established malignant T-cell clone. Am. J. Surg. Pathol. 2010, 34:1382-1387.
23. Liu Y., Zhang W. Identification of a new transmembrane adaptor protein that constitutively binds Grb2 in B cells. J. Leukoc. Biol. 2008, 84:842-851.
24. Mahadevan D., Spier C., Della Croce K., Miller S., George B., Riley C., Warner S., Grogan T.M., Miller T.P. Transcript profiling in peripheral T-cell lymphoma, not otherwise specified, and diffuse large B-cell lymphoma identifies distinct tumor profile signatures. Mol. Cancer Ther. 2005, 4:1867-1879.
25. Mori H., Ouchida R., Hijikata A., Kitamura H., Ohara O., Li Y., Gao X., Yasui A., Lloyd R.S., Wang J.Y. Deficiency of the oxidative damage-specific DNA glycosylase NEIL1 leads to reduced germinal center B cell expansion. DNA Repair (Amst.) 2009, 8:1328-1332.
26. National Center for Biotechnology Information Gene 2011, Available from URL: http://www.ncbi.nlm.nih.gov/gene (cited 7.11.11).
27. Pan Z., Shen Y., Du C., Zhou G., Rosenwald A., Staudt L.M., Greiner T.C., McKeithan T.W., Chan W.C. Two newly characterized germinal center B-cell-associated genes, GCET1 and GCET2, have differential expression in normal and neoplastic B cells. Am. J. Pathol. 2003, 163:135-144.
28. Paterson M.A., Hosking P.S., Coughlin P.B. Expression of the serpin centerin defines a germinal center phenotype in B-cell lymphomas. Am. J. Clin. Pathol. 2008, 130:117-126.
29. Piccaluga P.P., Agostinelli C., Califano A., Rossi M., Basso K., Zupo S., Went P., Klein U., Zinzani P.L., Baccarani M., Dalla Favera R., Pileri S.A. Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targets. J. Clin. Invest. 2007, 117:823-834.
30. Quintanilla-Martinez L., Franklin J.L., Guerrero I., Krenacs L., Naresh K.N., Rama-Rao C., Bhatia K., Raffeld M., Magrath I.T. Histological and immunophenotypic profile of nasal NK/T cell lymphomas from Peru: high prevalence of p53 overexpression. Hum. Pathol. 1999, 30:849-855.
31. Savage K.J., Ferreri A.J., Zinzani P.L., Pileri S.A. Peripheral T-cell lymphoma - not otherwise specified. Crit. Rev. Oncol. Hematol. 2011, 79:321-329.
32. Schmidlin H., Diehl S.A., Nagasawa M., Scheeren F.A., Schotte R., Uittenbogaart C.H., Spits H., Blom B. Spi-B inhibits human plasma cell differentiation by repressing BLIMP1 and XBP-1 expression. Blood 2008, 112:1804-1812.
33. Shi G.X., Harrison K., Wilson G.L., Moratz C., Kehrl J.H. RGS13 regulates germinal center B lymphocytes responsiveness to CXC chemokine ligand (CXCL)12 and CXCL13. J. Immunol. 2002, 169:2507-2515.
34. Sivaraman P., Lye W.C. Epstein-Barr virus-associated T-cell lymphoma in solid organ transplant recipients. Biomed. Pharmacother. 2001, 55:366-368.
35. Steinckwich N., Schenten V., Melchior C., Brechard S., Tschirhart E.J. An essential role of STIM1, Orai1, and S100A8-A9 proteins for Ca2+ signaling and FcgammaR-mediated phagosomal oxidative activity. J. Immunol. 2011, 186:2182-2191.
36. Takahashi E., Asano N., Li C., Tanaka T., Shimada K., Shimada S., Yoshino T., Kojima M., Hara K., Eimoto T., Nakamura S. Nodal T/NK-cell lymphoma of nasal type: a clinicopathological study of six cases. Histopathology 2008, 52:585-596.
37. Went P., Agostinelli C., Gallamini A., Piccaluga P.P., Ascani S., Sabattini E., Bacci F., Falini B., Motta T., Paulli M., Artusi T., Piccioli M., Zinzani P.L., Pileri S.A. Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score. J. Clin. Oncol. 2006, 24:2472-2479.
38. Zaheen A., Martin A. Activation-induced cytidine deaminase and aberrant germinal center selection in the development of humoral autoimmunities. Am. J. Pathol. 2011, 178:462-471.